Investigational Drugs Available
At Bristol Myers Squibb, we are doing everything we can to ensure that patients with serious or life-threatening diseases receive the benefit of our innovative medicines as quickly as possible. We welcome requests for early patient access from the physicians treating these patients.
Submitting a Request Form
Request forms must be submitted by the healthcare professional. Patient eligibility will be determined by Bristol Myers Squibb in accordance with established policies and procedures. Bristol Myers Squibb’s acceptance and processing of this application does not guarantee that access to the investigational product will be provided.
Current Programs: Early Patient Access (EPA) Programs
Early Patient Access Request (Other Products)